Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran

被引:55
作者
SJ Moghaddam
EN Haghighi
S Samiee
N Shahid
AR Keramati
S Dadgar
MR Zali
机构
[1] Research Center for Gastroenterology and Liver Disease Shaheed Beheshti University of Medical Sciences and Academy of Medical Sciences Iran
[2] Research Center for Gastroenterology and Liver Disease Shaheed Beheshti University of Medical Sciences and Academy of Medical Sciences Iran
关键词
Hepatocellular Carcinoma; Iran; Expression of p53; cyclinD1; RB1; c-fos and N-ras genes;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM: To study the effect of some genes especially those involved in cell cycle regulation on hepatocellular carcinoma. METHODS: Paraffin-embedded tissue samples of 25 patients (18 males and 7 females) with hepatocellular carcinoma were collected from 22 pathology centers in Tehran during 2000-2001, and stained using immunohistochemistry method (avidin-biotin-peroxidase) for detection of p53, cyclinD1, RB1, c-fos and N-ras proteins. RESULTS: Six (24%), 5 (20%), 12 (48%) and 2 samples (8%) were positive for p53, cyclinD1, C-fos and N-ras expression, respectively. Twenty-two (88%) samples had alterations in the G1 cell-cycle checkpoint protein expression (RB1 or cyclinD1). P53 positive samples showed a higher (9 times) risk of being positive for RB1 protein than p53 negative samples. Loss of expression of RB1 in association with p53 over-expression was observed in 4 (66.7%) of 6 samples. Loss of expression of RB1 was seen in all cyclinD1 positive, 20 (90.9%) N-ras negative, and 11 (50%) C-fos positive samples, respectively. CyclinD1 positive samples showed a higher (2.85 and 4.75 times) risk of being positive for c-fos and N-ras expression than cyclinD1 negative samples. CONCLUSION: The expression of p53, RB1 and c-fos genes appears to have a key role in the pathogenesis of hepatocellular carcinoma in Iran. Simultaneous overexpression of these genes is significantly associated with their loss of expression during development of hepatocellular carcinoma.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 5 条
[1]   Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma [J].
Sato, Y ;
Itoh, F ;
Hareyama, M ;
Satoh, M ;
Hinoda, Y ;
Seto, M ;
Ueda, R ;
Imai, K .
JOURNAL OF GASTROENTEROLOGY, 1999, 34 (04) :486-493
[2]  
Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma[J] . Kumiyo Ashida,Yosuke Kishimoto,Kentaro Nakamoto,Kouichirou Wada,Goshi Shiota,Yasuaki Hirooka,Yoshinori Kamisaki,Tadao Itoh,Hironaka Kawasaki.Journal of Cancer Research and Clinical Oncology . 1997 (9)
[3]  
Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas. Luo D,Liu QF,Gove C,Naomov N,Su JJ,Williams R. World Journal of Gastroenterology . 1998
[4]  
Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines. Farshid M,Tabor E. Journal of Medical Virology . 1992
[5]  
E f f e c t s o f S t a t 3 phosphorylation and expression of c-fos and c-jun proteins on hepatocarcinogenesis. F e n g D Y,Z h e n g H,J i a n g H Y. Hunan Yike Daxue Xuebao . 2001